Could secondary prevention of coronary heart disease be more effective?
Beta-adrenoblockers (BAB) in secondary prevention of coronary heart disease (CHD) are not always effective, due to non-achieved target heart rate (HR). The reasons for that could include medication intolerance, baseline bradycardia (HR<55 bpm), II-III Stage atrio-ventricular blocks, and acute...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2022 |
| _version_ | 1797882675256623104 |
|---|---|
| author | V. I. Makolkin |
| author_facet | V. I. Makolkin |
| author_sort | V. I. Makolkin |
| collection | DOAJ |
| description | Beta-adrenoblockers (BAB) in secondary prevention of coronary heart disease (CHD) are not always effective, due to non-achieved target heart rate (HR). The reasons for that could include medication intolerance, baseline bradycardia (HR<55 bpm), II-III Stage atrio-ventricular blocks, and acute episodes of generalized weakness when HR is reduced. In these situations, BAB could be effectively combined with ivabradine (10-15 mg/d). This combination provides an opportunity to achieve target HR levels (60-55 bpm). |
| first_indexed | 2024-04-10T03:38:28Z |
| format | Article |
| id | doaj.art-7eca2352c4fa48c992cf9ce30fd01c5e |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:38:28Z |
| publishDate | 2010-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-7eca2352c4fa48c992cf9ce30fd01c5e2023-03-13T07:23:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-02-019192961734Could secondary prevention of coronary heart disease be more effective?V. I. Makolkin0Московская медицинская академия им. И.М.Сеченова Росздрава. МоскваBeta-adrenoblockers (BAB) in secondary prevention of coronary heart disease (CHD) are not always effective, due to non-achieved target heart rate (HR). The reasons for that could include medication intolerance, baseline bradycardia (HR<55 bpm), II-III Stage atrio-ventricular blocks, and acute episodes of generalized weakness when HR is reduced. In these situations, BAB could be effectively combined with ivabradine (10-15 mg/d). This combination provides an opportunity to achieve target HR levels (60-55 bpm).https://cardiovascular.elpub.ru/jour/article/view/2022ишемическая болезнь сердцавторичная профилактикаβ-адреноблокаторыивабрадин |
| spellingShingle | V. I. Makolkin Could secondary prevention of coronary heart disease be more effective? Кардиоваскулярная терапия и профилактика ишемическая болезнь сердца вторичная профилактика β-адреноблокаторы ивабрадин |
| title | Could secondary prevention of coronary heart disease be more effective? |
| title_full | Could secondary prevention of coronary heart disease be more effective? |
| title_fullStr | Could secondary prevention of coronary heart disease be more effective? |
| title_full_unstemmed | Could secondary prevention of coronary heart disease be more effective? |
| title_short | Could secondary prevention of coronary heart disease be more effective? |
| title_sort | could secondary prevention of coronary heart disease be more effective |
| topic | ишемическая болезнь сердца вторичная профилактика β-адреноблокаторы ивабрадин |
| url | https://cardiovascular.elpub.ru/jour/article/view/2022 |
| work_keys_str_mv | AT vimakolkin couldsecondarypreventionofcoronaryheartdiseasebemoreeffective |